These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 27153507

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates.
    Chambers JE, Chambers HW, Meek EC, Pringle RB.
    Chem Biol Interact; 2013 Mar 25; 203(1):135-8. PubMed ID: 23123249
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotection From Organophosphate-Induced Damage by Novel Phenoxyalkyl Pyridinium Oximes in Rat Brain.
    Pringle RB, Meek EC, Chambers HW, Chambers JE.
    Toxicol Sci; 2018 Dec 01; 166(2):420-427. PubMed ID: 30496567
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.
    Shih TM, Skovira JW, O'Donnell JC, McDonough JH.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):207-14. PubMed ID: 20223229
    [Abstract] [Full Text] [Related]

  • 8. Reactivation by novel pyridinium oximes of rat serum and skeletal muscle acetylcholinesterase inhibited by organophosphates.
    Bennett JP, Meek EC, Chambers JE.
    J Biochem Mol Toxicol; 2024 Jul 06; 38(7):e23750. PubMed ID: 38952032
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats.
    Meek EC, Chambers HW, Pringle RB, Chambers JE.
    Toxicology; 2015 Oct 02; 336():79-83. PubMed ID: 26275814
    [Abstract] [Full Text] [Related]

  • 16. Amidine-oximes: reactivators for organophosphate exposure.
    Kalisiak J, Ralph EC, Zhang J, Cashman JR.
    J Med Chem; 2011 May 12; 54(9):3319-30. PubMed ID: 21438612
    [Abstract] [Full Text] [Related]

  • 17. In vitro reactivation of acetylcholinesterase using the oxime K027.
    Kuca K, Kassa J.
    Vet Hum Toxicol; 2004 Feb 12; 46(1):15-8. PubMed ID: 14748409
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
    Maček Hrvat N, Kalisiak J, Šinko G, Radić Z, Sharpless KB, Taylor P, Kovarik Z.
    Toxicol Lett; 2020 Mar 15; 321():83-89. PubMed ID: 31863869
    [Abstract] [Full Text] [Related]

  • 19. Effects of novel brain-penetrating oxime acetylcholinesterase reactivators on sarin surrogate-induced changes in rat brain gene expression.
    Dail ME, Brino MLM, Chambers JE.
    J Biochem Mol Toxicol; 2021 Jun 15; 35(6):1-10. PubMed ID: 33682265
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.